A detailed history of Eagle Bay Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Eagle Bay Advisors LLC holds 7,228 shares of MRK stock, worth $716,873. This represents 0.48% of its overall portfolio holdings.

Number of Shares
7,228
Previous 7,608 4.99%
Holding current value
$716,873
Previous $941,000 12.86%
% of portfolio
0.48%
Previous 0.58%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$111.15 - $128.97 $42,237 - $49,008
-380 Reduced 4.99%
7,228 $820,000
Q2 2024

Jul 26, 2024

BUY
$123.8 - $132.96 $195,975 - $210,475
1,583 Added 26.27%
7,608 $941,000
Q1 2024

May 08, 2024

SELL
$113.24 - $131.95 $21,289 - $24,806
-188 Reduced 3.03%
6,025 $794,000
Q4 2023

Feb 08, 2024

SELL
$100.18 - $109.02 $155,880 - $169,635
-1,556 Reduced 20.03%
6,213 $677,000
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $269,729 - $299,544
2,620 Added 50.88%
7,769 $799,000
Q2 2023

Aug 10, 2023

SELL
$108.61 - $118.38 $13,359 - $14,560
-123 Reduced 2.33%
5,149 $594,000
Q1 2023

Apr 24, 2023

SELL
$102.94 - $114.86 $34,999 - $39,052
-340 Reduced 6.06%
5,272 $560,000
Q4 2022

Jan 26, 2023

BUY
$87.44 - $112.11 $131,946 - $169,173
1,509 Added 36.78%
5,612 $0
Q3 2022

Nov 22, 2022

SELL
$84.53 - $94.96 $3,550 - $3,988
-42 Reduced 1.01%
4,103 $354,000
Q2 2022

Aug 19, 2022

BUY
$83.49 - $94.64 $98,935 - $112,148
1,185 Added 40.03%
4,145 $378 Million
Q1 2022

May 11, 2022

BUY
$73.51 - $82.4 $37,857 - $42,436
515 Added 21.06%
2,960 $243,000
Q4 2021

Jan 21, 2022

SELL
$72.28 - $90.54 $133,356 - $167,046
-1,845 Reduced 43.01%
2,445 $187,000
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $122,787 - $135,035
1,713 Added 66.47%
4,290 $323,000
Q2 2021

Jul 30, 2021

BUY
$70.31 - $77.77 $181,188 - $200,413
2,577 New
2,577 $205,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Eagle Bay Advisors LLC Portfolio

Follow Eagle Bay Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Bay Advisors LLC with notifications on news.